Oppositional Defiant Disorder
📧 Sign up to get email alerts when something new happens for Oppositional Defiant Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder [Phase 4]
Phase 4 clinical trial update describing medication strategies for reducing aggressive behavior in youths with ADHD. The study includes chil…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth [NA]
Clinical trial completed evaluating multi-family group therapy for reducing behavioral difficulties in youth with oppositional defiant disor…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Comparison of Two Psychosocial Therapies for Treating Children With Oppositional-Defiant Disorder [NA]
This clinical trial update reports a completed study comparing two psychosocial therapies for children with Oppositional Defiant Disorder.
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Resources to Enhance the Adjustment of Children (REACH) [NA]
The REACH trial conducted by the University of Pittsburgh is reported as completed and appears to study resources to enhance adjustment in c…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders [Phase 3]
Phase 3 study evaluating the efficacy and safety of risperidone for preventing relapse in children and adolescents with conduct and other di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Home Based Treatment for Drug Use in Early Adolescents [Phase 2]
Phase 2 clinical trial update on a home-based treatment for drug use in early adolescents, investigating conditions including Attention-Defi…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation [Phase 3]
Phase 3 study evaluating the safety and effectiveness of risperidone for conduct disorder and other disruptive behavior disorders in childre…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation [Phase 3]
Phase 3 trial comparing risperidone to placebo for the treatment of conduct disorder in children with mild to borderline mental retardation;…
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany [Phase 4]
Phase 4 trial in Germany comparing atomoxetine with placebo in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). [Phase 3]
Phase 3 Italian study evaluating the efficacy of atomoxetine for children and adolescents with attention-deficit/hyperactivity disorder and …
-
CLINICAL_TRIALS trial_result · 2008-11-18Clinical Trial Update: Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders [Phase 2]
Phase 2 trial of ziprasidone for severe conduct disorder and other disruptive behavior disorders has completed. The update does not include …
-
CLINICAL_TRIALS trial_result · 2008-10-31Clinical Trial Update: Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD [Phase 3]
Phase 3 trial comparing atomoxetine to placebo in children and adolescents with ADHD and oppositional defiant disorder has completed.